![Gina Mazzariello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gina Mazzariello
Consejero General en AMYLYX PHARMACEUTICALS, INC. .
Fortuna: 260 540 $ al 31/05/2024
Origen de la red de primer grado Gina Mazzariello.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 16 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Gina Mazzariello a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
Apnimed, Inc.
![]() Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
K-Gen, Inc.
![]() K-Gen, Inc. Miscellaneous Commercial ServicesCommercial Services K-Gen, Inc. is an American biotechnology company. The private company is based in San Francisco. | Miscellaneous Commercial Services | Director/Board Member | |
Artugen Therapeutics Ltd.
![]() Artugen Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Artugen Therapeutics Ltd. develops precision treatments for infections. The company was founded in 2015 and is headquartered in Concord, MA. | Pharmaceuticals: Generic | Director/Board Member | |
Cognoa, Inc.
![]() Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Director/Board Member | |
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Director/Board Member | |
Serica Technologies, Inc.
![]() Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
InCarda Therapeutics, Inc.
![]() InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Tufts University School of Medicine | College/University | Doctorate Degree | |
Atreaon, Inc.
![]() Atreaon, Inc. Pharmaceuticals: OtherHealth Technology Atreaon, Inc. develops proteins for diseases treatment. It operates as a pharmaceutical company that develops medicines for the treatment of arthritis. The company was founded on December 19, 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Other | Director/Board Member | |
ProterixBio, Inc.
![]() ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NUCANA PLC | Biotechnology | Director/Board Member | |
AKAMAI TECHNOLOGIES, INC. | Data Processing Services | Human Resources Officer | |
Adjuvance Technologies, Inc.
![]() Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Pharmaceuticals: Generic | Director/Board Member | |
Advanced Cell Diagnostics, Inc.
![]() Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Synchroneuron, Inc.
![]() Synchroneuron, Inc. Pharmaceuticals: MajorHealth Technology Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Major | Director/Board Member | |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Thyron Pharmaceuticals, Inc. | Chief Executive Officer | ||
DalCor Pharma UK Ltd.
![]() DalCor Pharma UK Ltd. BiotechnologyHealth Technology Founded in 2015, DalCor Pharma UK Ltd. is a subsidiary of DalCor Pharmaceuticals Canada, Inc. The company is based in Leatherhead, UK. The British company engages in research and experimental development on biotechnology. | Biotechnology | Director/Board Member | |
Revelar Biotherapeutics, Inc.
![]() Revelar Biotherapeutics, Inc. BiotechnologyHealth Technology Revelar Biotherapeutics is a biopharmaceutical company based in Bethesda, MD. Revelar Biotherapeutics, Inc. focuses on developing and commercializing breakthrough therapeutic antibody products to address critical unmet patient needs, particularly in the field of COVID-19 and other therapeutic areas. The company's management team has extensive expertise in clinical development, regulatory affairs, business development, and operations with leading pharmaceutical companies. Revelar was spun out of Twist Bioscience in November 2021 and has the ability to leverage Twist Biopharma's antibody discovery and optimization platform to license additional antibodies for non-COVID targets. The company's therapeutic areas of interest include oncology and infectious diseases. Revelar aims to combine its clinical development and commercialization capabilities with Twist's innovative technology platform and industry and academia collaborations to accelerate the discovery and delivery of transformative antibody therapeutics to meet patients' unmet needs. Revelar was founded by Kevin P. Malobisky, and the CEO is Glenn Marina. | Biotechnology | Director/Board Member | |
Allyx Therapeutics, Inc.
![]() Allyx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Allyx Therapeutics is an American clinical-stage biotechnology company founded in 2019 by a group of experienced biopharma industry executives, venture capitalists, and scientific experts. The company is based in an undisclosed location and aims to deliver a novel approach to preserve and protect synapses for people living with neurodegenerative diseases. Its lead compound, alx-001, is a first-in-class oral therapy with a unique mechanism of action at mglur5 currently in clinical development in Alzheimer's disease. The company is developing an oral drug that demonstrates reversal of learning and memory deficits due to Alzheimer's disease. The company was founded by Timothy Siegert, Stephen M. Bloch, Paul R. Fonteyne, and Stephen M. Bloch has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
American Cancer Society, Inc.
![]() American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GELESIS HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
COVETRUS, INC. | Packaged Software | Director/Board Member | |
Boehringer Ingelheim Animal Health USA, Inc.
![]() Boehringer Ingelheim Animal Health USA, Inc. BiotechnologyHealth Technology Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA. | Biotechnology | President | |
National Pharmaceutical Council
![]() National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman | |
Ypsomed AG
![]() Ypsomed AG Medical SpecialtiesHealth Technology Part of Ypsomed Holding AG, Ypsomed AG is a Swiss company that manufactures injection and infusion systems for self-medication and renowned diabetes. The company is based in Burgdorf, Switzerland. | Medical Specialties | Director/Board Member | |
Masters Pharmaceuticals Ltd.
![]() Masters Pharmaceuticals Ltd. Specialty StoresRetail Trade Masters Pharmaceuticals Ltd. provides global healthcare solutions. It distributes prescription and OTC drugs, medical devices and supplies. The firm offers acetylcysteine, aciclovir, amiloride hcl, amitriptyline, baclofen and budesonide products. It supplies advanced medicines to hospitals, pharmacists, clinics and Governments. The company was founded by Suzad Masters and Zulf Masters in 1984 and is headquartered in Elstree, the United Kingdom. | Specialty Stores | Director/Board Member | |
Revolo Biotherapeutics Ltd.
![]() Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Ma Pharmaceuticals, Inc. | Director/Board Member | ||
BIOVIE INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Rochester Christian University | College/University | Undergraduate Degree | |
Dolby Family Ventures LLC
![]() Dolby Family Ventures LLC Investment ManagersFinance Dolby Family Ventures (Dolby) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
Cognitive Clarity, Inc.
![]() Cognitive Clarity, Inc. Pharmaceuticals: OtherHealth Technology Cognitive Clarity, Inc. engages in the research and development of a line of memory supplements that target brain plaques and tangles that accumulate during normal aging. Its products include Percepta, percepta Sport and Percepta Professional. The company was founded by Alan Snow and Rudolph Tanzi in 2015 and is headquartered in Edmonds, WA. | Pharmaceuticals: Other | Founder | |
Tapimmune, Inc. | Chief Tech/Sci/R&D Officer | ||
G.D. Searle LLC | Corporate Officer/Principal | ||
Dlx Therapeutics L L C | Corporate Officer/Principal | ||
Rutgers Business School | College/University | Masters Business Admin | |
Universite Paris Est Creteil Val De Marne | College/University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 43 |
Reino Unido | 6 |
Francia | 3 |
Suiza | 2 |
Sectorial
Health Technology | 25 |
Consumer Services | 10 |
Commercial Services | 6 |
Finance | 3 |
Technology Services | 3 |
Operativa
Director/Board Member | 70 |
Corporate Officer/Principal | 27 |
Independent Dir/Board Member | 26 |
Chief Tech/Sci/R&D Officer | 14 |
Undergraduate Degree | 11 |
Las relaciones más conectadas
Insiders | |
---|---|
Isaac Cheng | 25 |
Paul R. Fonteyne | 25 |
George Milne | 24 |
Camille Bedrosian | 18 |
Patrick Yeramian | 13 |
Jim Frates | 11 |
Kari Firestone | 9 |
Daphne Quimi | 8 |
Debra L. Canner | 6 |
Rudy Tanzi | 6 |
Margaret Olinger | 4 |
Josh Cohen | 4 |
Justin Klee | 3 |
Lindsey Allen | 1 |
- Bolsa de valores
- Insiders
- Gina Mazzariello
- Conexiones Empresas